Mass SpectrometryTDM Testing ProjectMulti-Antiviral Drug Panel

Multi-Antiviral Drug Panel

Abbreviation：ATVMethod：Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)

Product Overview
  • Analytes
    Elbasvir、Bictegravir、Dolutegravir、Raltegravir、Abacavir、 Tenofovir、Lamivudine、Zidovudine、Emtricitabine、Tenofovir Alafenamide、Efavirenz、Lopinavir、Ritonavir
  • Example Clinical Applications
    Therapeutic drug monitoring of antiviral agents in the Departments of Infectious Diseases, Hepatology, and Gastroenterology.
  • Sample Type
    Plasma
  • Background

    ntiviral drugs inhibit viral replication rather than directly killing or destroying viruses. Their antiviral mechanisms include: (1) preventing viral attachment to host cells; (2) blocking viral entry into host cells; (3) inhibiting viral nucleic acid replication to suppress viral proliferation; (4) inhibiting viral protein synthesis; (5) inducing host cells to produce antiviral proteins that suppress the replication of various viruses; and (6) interfering with viral release from host cells.
    Therapeutic monitoring of multiple antiviral drugs can improve treatment efficacy, reduce the risk of adverse drug reactions, and provide valuable data for the diagnosis and management of drug toxicity.

  • Packing Specification
    o4024-1744179033987.png